972 suppliers hold GMP certificates from two or more regulators. Breadth of recognition is a practical proxy for how many markets a site can already supply without a fresh inspection.
| Supplier | Regulators | Certified by | US DMFs | Country |
|---|---|---|---|---|
| Fresenius Kabi | 18 | EMA, ZLG (DE), ANVISA (Brazil) +15 | 32 | Sweden |
| Sandoz | 15 | EMA, COFEPRIS (MX), ANSM (FR) +12 | 40 | Switzerland |
| Pfizer Brasil Ltda | 15 | ANVISA (Brazil), EAEU_EEC, BPOM (ID) +12 | — | Brazil |
| Siegfried | 14 | EDQM, ANSM (FR), ZLG (DE) +11 | 94 | Germany |
| Abbvie | 14 | EAEU_EEC, ZLG (DE), HSA (SG) +11 | 7 | United States |
| Gsk Vaccines | 14 | MHRA (UK), ZLG (DE), NAFDAC (NG) +11 | 10 | United Kingdom |
| Gilead Sciences | 13 | EMA, ZLG (DE), COFEPRIS (MX) +10 | 3 | United States |
| Viatris | 13 | EMA, ZLG (DE), ANSM (FR) +10 | — | United States |
| MSN Laboratories | 12 | EDQM, EMA, ANVISA (Brazil) +9 | 517 | India |
| Hetero | 12 | EMA, US FDA, ANVISA (Brazil) +9 | 380 | India |
| Cipla | 12 | EMA, CDSCO (India), ANVISA (Brazil) +9 | 161 | India |
| Macleods Pharmaceuticals | 12 | EDQM, CDSCO (India), MHRA (UK) +9 | 129 | India |
| Otsuka Pharmaceutical India | 12 | BPOM (ID), US FDA, ZLG (DE) +9 | 1 | India |
| Bayer S/A | 11 | BPOM (ID), ZLG (DE), COFEPRIS (MX) +8 | 26 | Brazil |
| Novartis | 11 | ZLG (DE), ANSM (FR), EMA +8 | 10 | Switzerland |
| Sanofi | 11 | ANSM (FR), MFDS (Korea), EMA +8 | 11 | France |
| Bristol-Myers Squibb | 11 | MHRA (UK), EMA, UZPHARM (UZ) +8 | — | United States |
| Ferring | 11 | ZLG (DE), BPOM (ID), HSA (SG) +8 | — | Germany |
| Glenmark Pharmaceuticals s.r.o | 11 | EMA, CDSCO (India), ANVISA (Brazil) +8 | — | Czech Republic |
| Sandoz S/A | 11 | MHRA (UK), ANSM (FR), EMA +8 | — | Switzerland |
| Dr Reddy's Laboratories | 10 | ANVISA (Brazil), EMA, US FDA +7 | 279 | India |
| Piramal Pharma | 10 | MHRA (UK), EMA, US FDA +7 | 62 | India |
| Teva | 10 | EMA, MHRA (UK), US FDA +7 | 22 | Israel |
| Boehringer Ingelheim Pharma Gmbh | 10 | ZLG (DE), EMA, ANVISA (Brazil) +7 | 6 | Germany |
| Lupin | 9 | EMA, CDSCO (India), MHRA (UK) +6 | 135 | India |
| Corden Pharma | 9 | ANSM (FR), EMA, ZLG (DE) +6 | 17 | France |
| Astrazeneca Ab | 9 | EMA, MFDS (Korea), BPOM (ID) +6 | 3 | Sweden |
| Eli Lilly And | 9 | EMA, MFDS (Korea), ZLG (DE) +6 | — | United States |
| Baxter Hospitalar Ltda | 9 | ANSM (FR), MFDS (Korea), EMA +6 | — | Brazil |
| Genzyme | 9 | MFDS (Korea), MHRA (UK), EAEU_EEC +6 | — | United States |
| Sanofi | 9 | ANSM (FR), ZLG (DE), EMA +6 | — | France |
| Biocon | 8 | ANVISA (Brazil), EMA, CDSCO (India) +5 | 69 | India |
| Ajinomoto | 8 | US FDA, TMDA (TZ), MFDS (Korea) +5 | 34 | Japan |
| Alkem Laboratories | 8 | CDSCO (India), NAFDAC (NG), EMA +5 | 37 | India |
| GE Healthcare | 8 | ZLG (DE), EMA, EDQM +5 | 13 | Norway |
| Advanced Accelerator Applications | 8 | ANSM (FR), EMA, ZLG (DE) +5 | — | France |
| Amgen | 8 | EMA, US FDA, HSA (SG) +5 | — | United States |
| Daiichi Sankyo Europe | 8 | ANSM (FR), ZLG (DE), MFDS (Korea) +5 | — | Germany |
| Delpharm Huningue Sas | 8 | ANSM (FR), EAEU_EEC, ANVISA (Brazil) +5 | — | France |
| Zydus Lifesciences | 7 | CDSCO (India), EMA, ANVISA (Brazil) +4 | 150 | India |
| Laurus Labs | 7 | EMA, MFDS (Korea), US FDA +4 | 118 | India |
| Micro Labs | 7 | EMA, CDSCO (India), NAFDAC (NG) +4 | 55 | India |
| Natco Pharma | 7 | ANVISA (Brazil), EMA, US FDA +4 | 102 | India |
| Gland Pharma | 7 | ANVISA (Brazil), EMA, US FDA +4 | 75 | India |
| Torrent Pharmaceuticals | 7 | CDSCO (India), EMA, ANVISA (Brazil) +4 | 39 | India |
| BASF | 7 | ANSM (FR), ZLG (DE), US FDA +4 | 17 | Germany |
| FDC Limited | 7 | EDQM, EMA, MHRA (UK) +4 | 15 | India |
| Bayer | 7 | ZLG (DE), EMA, ANVISA (Brazil) +4 | — | Finland |
| Sanofi Winthrop Industrie | 7 | ANSM (FR), ANVISA (Brazil), EMA +4 | — | France |
| North China Pharmaceutical | 7 | MFDS (Korea), EMA, US FDA +4 | 9 | China |
| Leo Pharma | 7 | ANVISA (Brazil), EMA, US FDA +4 | 2 | Denmark |
| Lonza | 7 | EMA, MHRA (UK), HSA (SG) +4 | 5 | Switzerland |
| Reyoung Pharmaceutical | 7 | ANVISA (Brazil), MFDS (Korea), INVIMA (CO) +4 | 9 | China |
| Farmak | 7 | INVIMA (CO), MHRA (UK), NCELS (KZ) +4 | 6 | Czech Republic |
| Ajanta Pharma | 7 | CDSCO (India), UZPHARM (UZ), FDA (GH) +4 | 4 | India |
| Hospira | 7 | MFDS (Korea), EAEU_EEC, ANVISA (Brazil) +4 | 2 | United States |
| Sanofi Pasteur | 7 | ANSM (FR), NAFDAC (NG), EAEU_EEC +4 | — | France |
| Aurobindo Pharma | 7 | EMA, EAEU_EEC, US FDA +4 | — | India |
| Biological E | 7 | ANVISA (Brazil), EMA, FDA (GH) +4 | — | India |
| Idt Biologika | 7 | ZLG (DE), ANVISA (Brazil), MFDS (Korea) +4 | — | Germany |
| Les Laboratoires Servier Industrie | 7 | ANSM (FR), MFDS (Korea), TMDA (TZ) +4 | — | France |
| Organon Pharma (Uk) | 7 | BPOM (ID), ANVISA (Brazil), MHRA (UK) +4 | — | United Kingdom |
| Serum Institute Of India | 7 | EMA, ANVISA (Brazil), MHRA (UK) +4 | — | India |
| Servier (Ireland) Industries | 7 | NAFDAC (NG), EAEU_EEC, HSA (SG) +4 | — | Ireland |
| Alembic Pharmaceuticals | 6 | CDSCO (India), EMA, US FDA +3 | 145 | India |
| Ipca Laboratories | 6 | CDSCO (India), MHRA (UK), EMA +3 | 52 | India |
| Mankind Pharma | 6 | EMA, CDSCO (India), TMDA (TZ) +3 | 64 | India |
| Orchid Pharma | 6 | CDSCO (India), EMA, MHRA (UK) +3 | 45 | India |
| Synthimed Labs | 6 | TMDA (TZ), NAFDAC (NG), EAEU_EEC +3 | 40 | India |
| Ami Lifesciences | 6 | EDQM, CDSCO (India), MFDS (Korea) +3 | 39 | India |
| Cadila Pharmaceuticals | 6 | CDSCO (India), EMA, US FDA +3 | 32 | India |
| Excella Gmbh | 6 | ZLG (DE), ANVISA (Brazil), EMA +3 | 26 | Germany |
| USV | 6 | EMA, MHRA (UK), CDSCO (India) +3 | 30 | India |
| Qilu Pharmaceutical | 6 | EDQM, EMA, US FDA +3 | 31 | China |
| Lek Pharmaceuticals | 6 | ANVISA (Brazil), NCELS (KZ), EMA +3 | 26 | Slovenia |
| PolyPeptide | 6 | ANSM (FR), EDQM, US FDA +3 | 27 | Sweden |
| Unichem Laboratories | 6 | EMA, MHRA (UK), US FDA +3 | — | India |
| Reliance Life Sciences | 6 | EMA, ANVISA (Brazil), EAEU_EEC +3 | 13 | India |
| Astrazeneca Pharmaceuticals Lp | 6 | ANVISA (Brazil), US FDA, MHRA (UK) +3 | 3 | United States |
| Ucb Pharma | 6 | MHRA (UK), ZLG (DE), EMA +3 | 2 | Belgium |
| Jewim Pharmaceutical (Shandong) | 6 | INVIMA (CO), NAFDAC (NG), TMDA (TZ) +3 | 1 | China |
| Themis Medicare | 6 | NAFDAC (NG), EMA, FDA (GH) +3 | 1 | India |
| AlfaSigma | 6 | ANVISA (Brazil), EMA, MFDS (Korea) +3 | — | Italy |
| Annora Pharma | 6 | ANVISA (Brazil), EAEU_EEC, NAFDAC (NG) +3 | — | India |
| AstraZeneca UK | 6 | TMDA (TZ), MHRA (UK), ANVISA (Brazil) +3 | — | United Kingdom |
| B. Braun Melsungen | 6 | ZLG (DE), EMA, ANVISA (Brazil) +3 | — | Germany |
| Baxalta Us | 6 | MFDS (Korea), ANVISA (Brazil), COFEPRIS (MX) +3 | — | United States |
| Bharat Serums and Vaccines | 6 | EMA, FDA (GH), NAFDAC (NG) +3 | — | India |
| Eisai | 6 | ZLG (DE), MFDS (Korea), HSA (SG) +3 | — | Japan |
| Famar A.V.E | 6 | MINPROMTORG (RU), ZLG (DE), EMA +3 | — | Greece |
| Genentech | 6 | ANSM (FR), US FDA, HSA (SG) +3 | — | United States |
| Getz Pharma | 6 | NAFDAC (NG), EAEU_EEC, DRAP (PK) +3 | — | Pakistan |
| Glaxo Wellcome Production | 6 | ANSM (FR), ANVISA (Brazil), MFDS (Korea) +3 | — | France |
| Gufic Biosciences | 6 | EMA, CDSCO (India), NAFDAC (NG) +3 | — | India |
| Haupt Pharma Amareg | 6 | ZLG (DE), EAEU_EEC, ANVISA (Brazil) +3 | — | Germany |
| Inventia Healthcare | 6 | EMA, NAFDAC (NG), ANVISA (Brazil) +3 | — | India |
| Lilly | 6 | MFDS (Korea), ANVISA (Brazil), AEMPS (ES) +3 | — | Spain |
| Msd International Gmbh (Puerto Rico Branch) | 6 | EMA, ANVISA (Brazil), HSA (SG) +3 | — | United States |
| Novartis Pharma Produktions | 6 | ZLG (DE), ANVISA (Brazil), MFDS (Korea) +3 | — | Germany |
| Opella Healthcare Brazil Ltda | 6 | ANSM (FR), ANVISA (Brazil), EMA +3 | — | Brazil |
Showing the top 100 of 972. Every row links to its full profile; the complete set is on the supplier index.
Every number on this page is counted from published registers — nothing is modelled or estimated. Records last refreshed 9 July 2026. How we count our figures.
Tell Fred what you're working on and ask which records can help.
Chat with Fred, your AI analyst